By examining the 552 drugs in the drug-gene interaction database (DGIdb)41, we found that the drug Roniciclib significantly interacted with all three gene signatures: the ESC-like cancer genes, the MYCN-dependently expressed genes and the HR genes (FDR < 0.05, OR > 2, with five or more intersection of genes). The gene discussed is MYCN; the disease is cancer.